DRUG — Bright Minds Biosciences Share News
0.000.00%
Last trade - 00:00- CA$721.85m
- CA$414.09m
Brief: Bright Minds Biosciences Announces Pricing Of Upsized US$175 Million Public Offering Of Common Stock At $90.00 Per Share
Bright Minds Biosciences falls after $100 mln equity offering launched
Brief: Bright Minds To Announce Topline Results For BMB-101 Phase 2 Trial In On Jan 6
Brief: Bright Minds Biosciences Files For Offering Of Up To 1.6 Million Common Shares By The Selling Securityholders
Bright Minds Bio hits record high after private placement
Brief: Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement
Brief: Bright Minds Biosciences Says Financial Runway Extending Into 2026
Brief: Bright Minds Biosciences Announces Receipt Of Nasdaq Deficiency Letter Regarding Independent Director And Audit Committee Requirements
Brief: Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. As Chief Medical Officer
Brief: Bright Minds Biosciences Announces Appointment Of Doug Williamson To Board Of Directors
Bright Minds Biosciences surges on stock-and-warrant offering
Brief: Bright Minds Biosciences Announces Application To List On Nasdaq
Brief: Bright Minds Biosciences Appoints New Board Member And Expands Leadership Team